CoMentis
Latest round
- Series E
Last raised
- Mar 2016
Total raised
- $87M
Investors
- 6
About CoMentis
Founded in 2004 and is based in South San Francisco, California. CoMentis, Inc. is a biotech company, engages in the research, discovery, and development of small-molecule drugs to treat neurovascular diseases.
Who invested in CoMentis
6 investors across 7 rounds
See all investors in CoMentis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Mar 2, 2016
Amount
$4.5M
Investors
Series D
Jun 5, 2008
Amount
$20M
Investors
Series C
Oct 24, 2007
Amount
$12M
Investors
Series B
Aug 23, 2007
Amount
$15M
Investors
Series B
Mar 1, 2007
Amount
$12M
Investors
Series B
Sep 21, 2006
Amount
$20M
Investors
Series A
Feb 15, 2006
Amount
$3M
Investors
Questions about CoMentis
Who invested in CoMentis?
CoMentis has 6 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CoMentis raised?
CoMentis has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did CoMentis last raise money?
CoMentis's most recent round on record is a Series E, in Mar 2016.
What does CoMentis do?
Founded in 2004 and is based in South San Francisco, California.
Where is CoMentis headquartered?
CoMentis is headquartered in San Francisco, US.
Which VCs invest in companies like CoMentis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CoMentis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like CoMentis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.